Search

everythinglearnresearchcommunity

for

Search:↓

Cytotoxic T cells cause hair loss in chronic alopecia areata.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

A man with rare Lichen Planopilaris lost body hair, not scalp hair, and treatment stopped itching but didn't regrow hair.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Azathioprine may be an effective treatment for severe hair loss.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Alopecia Areata might be linked to Crohn's disease.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

The Hair India 2010 conference introduced a new hair loss classification and highlighted advanced diagnostic techniques in trichology.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Adalimumab can cause complete hair loss in rare cases.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Two transplant patients on cyclosporine unexpectedly developed hair loss.